Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

    Related Conference of Vaccines for Immune Mediated Diseases

    September 07-08, 2026

    38th Annual Congress on Vaccine and Clinical Trials

    London, UK
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain
    September 28-29, 2026

    8th World Congress on Vaccine and Immunology

    Toronto, Canada
    November 16-17, 2026

    7th International Conference on Vaccine Research

    Tokyo, Japan

    Vaccines for Immune Mediated Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in